Suchergebnisse - "Vavougios, George"

PubPharm (7)

1

Cerebrovascular Disease and Sleep-Disordered Breathing Need to Be Accounted for in Cognitive Impairment Following COVID-19

enthalten in: JAMA psychiatry | 2022

von Vavougios, G. | Stavrou, V. | Gourgoulianis, K.

CommentOn: JAMA Psychiatry. 2022 May 1;79(5):486-497. - PMID 35319743

2

SARS-CoV-2 and type I interferon signaling in brain endothelial cells : Blurring the lines between friend or foe

enthalten in: Stem cell reports | 2022

von Vavougios, G. | Zarogiannis, S. | Hadjigeorgiou, G. | +2

CommentOn: Stem Cell Reports. 2022 Feb 8;17(2):307-320. - PMID 35063125

3

Reader response : Miller Fisher syndrome and polyneuritis cranialis in COVID-19

enthalten in: Neurology | 2020

von Vavougios, G.

CommentOn: Neurology. 2020 Aug 4;95(5):e601-e605. - PMID 32303650

4

The continuum of SARS-CoV-2's neurotropism and the potential for immune-mediated neuronal injury

enthalten in: Seizure | 2020

von Vavougios, G.

CommentOn: Seizure. 2020 May;78:109-112. - PMID 32344366

5

Host proteases as determinants of coronaviral neurotropism and virulence

enthalten in: Brain, behavior, and immunity | 2020

von Vavougios, G.

CommentOn: Brain Behav Immun. 2020 Jul;87:18-22. - PMID 32240762

6

Potentially irreversible olfactory and gustatory impairments in COVID-19 : Indolent vs. fulminant SARS-CoV-2 neuroinfection

enthalten in: Brain, behavior, and immunity | 2020

von Vavougios, G.

CommentOn: Int J Infect Dis. 2020 May;94:55-58. - PMID 32251791

7

Letter to the editor : The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in developing a COVID-19 comorbidity-based host risk score

enthalten in: Critical care (London, England) | 2020

von Vavougios, G.

CommentOn: Crit Care. 2020 Mar 18;24(1):108. - PMID 32188484

1
[1]